These studies also highlight the significance of immunomodulation, the number of tumor-infiltrating lymphocytes, and the expression of programmed death-ligand (PD-L1) to the disease prognosis and treatment outcome pertaining to human BC [16,22,23,24]. The gene discussed is CD274; the disease is breast cancer.